Bausch Health appoints Jean-Jacques Charhon as CFO, Aimee Lenar as EVP US Pharma

Bausch Health Companies Inc.

Jean-Jacques Charhon named CFO effective Aug 19, 2024; base salary $700K, target bonus 60%, equity grants ~$3M.
Charhon receives one-time sign-on cash bonus of $300K and sign-on equity grant of $3.5M (50% RSUs, 50% PSUs).
Interim CFO John Barresi returns to SVP, Controller role; granted $350K retention RSU award vesting over 3 years.
Barresi's enhanced severance extended to Dec 31, 2025; bi-weekly $5K stipend extended to Sep 30, 2024.
Aimee Lenar joined Jul 15, 2024 as EVP US Pharma, leading Salix, Neurology, Generics, Market Access.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

John S. Barresi

Senior Vice President, Controller and Chief Accounting Officer

BHC · Bausch Health Companies Inc.

Effective: 2024-08-19
Successor: Jean-Jacques Charhon
Filed: July 19, 2024, 7:59 PM ET

John S. Barresi, who has served as the Company’s interim Chief Financial Officer since October 2023, will no longer act in this capacity and will continue in his role as Senior Vice President, Controller and Chief Accounting Officer.

Appointed

Jean-Jacques Charhon

Executive Vice President and Chief Financial Officer

BHC · Bausch Health Companies Inc.

Effective: 2024-08-19
Filed: July 19, 2024, 7:59 PM ET

On July 15, 2024, the Board of Directors (the “Board”) of Bausch Health Companies Inc. (the “Company”) appointed Jean-Jacques Charhon as the Company’s Executive Vice President and Chief Financial Officer, effective as of August 19, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John S. Barresi changed role as Senior Vice President, Controller and Chief Accounting Officer at Bausch Health Companies Inc..

Action: will no longer act in this capacity and will continue
Role: Senior Vice President, Controller and Chief Accounting Officer

Exact text from the filing

John S. Barresi, who has served as the Company’s interim Chief Financial Officer since October 2023, will no longer act in this capacity and will continue in his role as Senior Vice President, Controller and Chief Accounting Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jean-Jacques Charhon was appointed as Executive Vice President and Chief Financial Officer at Bausch Health Companies Inc..

Action: appointed
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On July 15, 2024, the Board of Directors (the “Board”) of Bausch Health Companies Inc. (the “Company”) appointed Jean-Jacques Charhon as the Company’s Executive Vice President and Chief Financial Officer, effective as of August 19, 2024.

View on SEC.gov

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000950103-24-010257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.